Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Organoids Market?

The size of the organoids market has seen substantial growth in the past few years. It is projected to increase from $3.98 billion in 2024 to $4.83 billion in 2025, marking a compound annual growth rate (CAGR) of 21.3%. The significant growth in the historic period is attributed to advancements in biomedical research, the necessity for drug discovery and development, the demand for disease modeling, the trends towards personalized medicine, and regulatory support.

What Growth Rate Is Forecasted for the Organoids Market by 2029?

Expectations are high for the organoids market size to witness explosive growth in the coming years. The market is projected to reach “$10.82 billion by 2029, growing at a compound annual growth rate (CAGR) of 22.3%. The anticipated growth during the forecast period can be tied to the rising incidence of chronic diseases, advancements in genome editing techniques, increased emphasis on stem cell research, strategic collaborations and partnerships, and efforts in clinical translations. Major trends to watch in the predicted timeframe include the use of organoids in regenerative medicine and in vivo imaging techniques, as well as collaborations to develop multi-organoid systems. The challenges of ethical and legal considerations, alongside commercialization and market expansion, are also significant factors to consider.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10787&type=smp

Which Key Companies Are Shaping the Future of the Organoids Market?

Major companies operating in the organoids market include Cellesce Ltd., STEMCELL Technologies, HUB Organoids, DefiniGEN, 3Dnamics Inc., OcellO B.V., Organoid Therapeutics, PeproTech Inc., QGel SA, Corning Incorporated, Thermo Fisher Scientific, Trevigen Inc., Path BioAnalytics, R&D Systems, Merck KGaA, 3D BioMatrix Inc., 3D Biotek LLC, AMS Biotechnology (Europe) Limited, Greiner Bio-One, 3-D Matrix, InSphero AG, Synthego Corporation, Axol Bioscience Ltd., TissUse GmbH, CytoSMART Technologies BV, EMD Millipore Corporation, Epithelix Sàrl

Which Factors Are Driving Demand in the Organoids Industry?

The anticipated enlargement of the organoid market is influenced by the surge in both chronic and infectious diseases. Chronic illnesses, which endure for longer than a year needing ongoing medical attention, have utilized organoids for detailed study. Organoids are capable of providing collection of accurate and reliable data regarding pathogen biology and pharmaceutical assessments. Thus, this surge of chronic and contagious diseases will indeed augment the organoid market. For example, in June 2024, the National Health Service, a publicly funded health facility based in the UK, reported around 3,615,330 individuals in line for GP registration identified with non-diabetic hyperglycemia or pre-diabetes. Comparing it with 2023’s total of 3,065,825, this growth is approximately a fifth (18%). Therefore, the escalating cases of chronic ailments will stimulate the growth of the organoid market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10787&type=smp

How Is the Organoids Market Segmented by Several Divisions?

The organoids market covered in this report is segmented –

1) By Product: Hepatic Organoid, Colorectal Organoid, Intestinal Organoid, Other Organoid

2) By Source: Pluripotent Stem Cells, Organ-Specific Adult Stem Cells

3) By Application: Developmental Biology, Disease Pathology Of Infectious Disease, Regenerative Medicine, Drug Toxicity And Efficacy Testing, Drug Discovery And Personalized Medicine, Other Applications

4) By End-User: Hospitals And Diagnostic Centers, Biotechnology And Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Hepatic Organoid: Hepatic Stem Cell-Derived Organoids, Primary Liver Cell-Derived Organoids, Liver Tumor Organoids

2) By Colorectal Organoid: Colonic Organoids, Rectal Organoids, Colorectal Cancer Organoids

3) By Intestinal Organoid: Small Intestinal Organoids, Enteroid Organoids, Intestinal Stem Cell-Derived Organoids

4) By Other Organoid: Pancreatic Organoids, Brain Organoids, Kidney Organoids, Lung Organoids, Others

What are the Emerging Market Trends Driving the Growth of the Organoids Industry?

Advancements in technology are becoming increasingly popular in the organoid market – a trend that is largely being driven by major industry players launching new organoid-focused technologies to maintain their market dominance. For example, MIMETAS, a Netherlands-based organisation that specialises in developing models of human tissue and disease, introduced a newly-formulated type of adult stem cell (ASC)-derived tubular organoids in March 2023. This innovative product line known as OrganoReady, features organoids designed as perfused 3D tubular structures with access points on both their apical and basal sides. This is all possible thanks to the OrganoPlate, a patented microfluidic platform. The latest organoid leverages state-of-the-art technology for mechanistic toxicology and the study of drug-induced organ injury.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/organoids-global-market-report

Which Regions Are Driving Growth in the Organoids Market?

North America was the largest region in the organoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global organoids market size forecast period. The regions covered in the organoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10787

This Report Delivers Insight On:

1. How big is the organoids market, and how is it changing globally?

2. Who are the major companies in the organoids market, and how are they performing?

3. What are the key opportunities and risks in the organoids market right now?

4. Which products or customer segments are growing the most in the organoids market?

5. What factors are helping or slowing down the growth of the organoids market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model